TipRanks
Advertisement
Advertisement

MX:MRK Stock Latest News

Perspective Therapeutics announces trial collaboration agreement with Merck
The FlyPerspective Therapeutics announces trial collaboration agreement with Merck
1d ago
MRK
CATX
Merck price target raised to $172 from $150 at HSBC
PremiumThe Fly
Merck price target raised to $172 from $150 at HSBC
5d ago
MRK
Leerink ups Merck price target on pipeline momentum
PremiumThe Fly
Leerink ups Merck price target on pipeline momentum
6d ago
MRK
Merck price target raised to $161 from $127 at Leerink
PremiumThe Fly
Merck price target raised to $161 from $127 at Leerink
6d ago
MRK
Merck price target raised to $170 from $146 at Guggenheim
PremiumThe Fly
Merck price target raised to $170 from $146 at Guggenheim
7d ago
MRK
MRNA
Merck price target raised to $170 from $150 at Wells Fargo
PremiumThe FlyMerck price target raised to $170 from $150 at Wells Fargo
11d ago
MRK
H.C. Wainwright views Novartis, Alteogen pact as negative for Halozyme
Premium
The Fly
H.C. Wainwright views Novartis, Alteogen pact as negative for Halozyme
13d ago
MRK
NVS
mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley
Premium
The Fly
mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley
18d ago
MRK
BNTX
Salesforce’s partnerships, acquisitions in focus ahead of Q2 earnings
PremiumThe Fly
Salesforce’s partnerships, acquisitions in focus ahead of Q2 earnings
20d ago
CRM
CVS
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
20d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
21d ago
ABT
BMY
After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)
PremiumTipRanks Newswire
After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)
21d ago
MRK
MRNA
Merck price target raised to $170 from $145 at Argus
PremiumThe FlyMerck price target raised to $170 from $145 at Argus
21d ago
MRK
Merck price target raised to $180 from $155 at Wolfe Research
Premium
The Fly
Merck price target raised to $180 from $155 at Wolfe Research
21d ago
MRK
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
Premium
The Fly
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
22d ago
MRK
GILD
Merck & Company Soars on Breakthrough Cancer Vaccine Hopes
PremiumWeekend Updates
Merck & Company Soars on Breakthrough Cancer Vaccine Hopes
24d ago
MRK
Merck price target raised to $160 from $140 at Goldman Sachs
PremiumThe Fly
Merck price target raised to $160 from $140 at Goldman Sachs
25d ago
MRK
Midday Fly By: Walmart reports Q2 beat, Trump asks Congress to pass Clarity Act
PremiumThe Fly
Midday Fly By: Walmart reports Q2 beat, Trump asks Congress to pass Clarity Act
26d ago
DE
TP
Etsy upgraded, TJX downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Etsy upgraded, TJX downgraded: Wall Street’s top analyst calls
26d ago
W
ADI
Merck price target raised to $170 from $142 at BMO Capital
PremiumThe FlyMerck price target raised to $170 from $142 at BMO Capital
26d ago
MRK
Tempus AI price target raised to $80 from $70 at BTIG
Premium
The Fly
Tempus AI price target raised to $80 from $70 at BTIG
26d ago
MRK
TEM
Merck price target raised to $175 from $145 at UBS
Premium
The Fly
Merck price target raised to $175 from $145 at UBS
26d ago
MRK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >